PBE vs. BOUT ETF Comparison
Comparison of PowerShares Dynamic Biotech & Genome (PBE) to Innovator IBD Breakout Opportunities ETF (BOUT)
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Grade (RS Rating)
Last Trade
$68.86
Average Daily Volume
6,628
30
BOUT
Innovator IBD Breakout Opportunities ETF
BOUT Description
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified. BOUT uses technical analysis to find stocks that are likely to breakout. The funds index relies on an algorithm that establishes a base price (a recent high) for each eligible security. The index then follows the trend for each stock. Selected stocks are ranked by a combination of relative strength and fundamental factors, and then weighted in fixed tiers according to this ranking. In addition, BOUT will move 50% of its portfolio into T-bills based on market signals: a rapid increase in either margin debt or overall stock prices, combined with slowing reversing momentum in the S&P 500. The T-bill position will remain in place until the S&P 500 falls by 50% or show indications of rising momentum. BOUT is rebalanced and reconstituted weekly after the close on Friday. The frequent rebalance schedule means the fund will be highly responsive to the technical factors that drive its strategy, but could also experience high turnover.Grade (RS Rating)
Last Trade
$37.04
Average Daily Volume
1,998
44
Performance
| Period | PBE | BOUT |
|---|---|---|
| 30 Days | -0.97% | 2.00% |
| 60 Days | -3.80% | 1.00% |
| 90 Days | 0.98% | 7.18% |
| 12 Months | 26.96% | 27.28% |
PBE Overweight 28 Positions Relative to BOUT
| Symbol | Grade | Weight | |
|---|---|---|---|
| ILMN | A | 5.81% | |
| UTHR | A | 5.33% | |
| ALNY | C | 5.18% | |
| AMGN | C | 4.97% | |
| BIIB | F | 4.59% | |
| NBIX | C | 4.2% | |
| REGN | F | 3.96% | |
| BMRN | F | 3.8% | |
| MNKD | A | 3.67% | |
| EXEL | A | 3.54% | |
| XNCR | A | 3.45% | |
| INCY | A | 3.17% | |
| PTGX | B | 3.17% | |
| VCYT | A | 3.08% | |
| TGTX | A | 3.06% | |
| TECH | B | 3.01% | |
| CPRX | A | 2.96% | |
| NTRA | B | 2.96% | |
| BCRX | A | 2.86% | |
| BPMC | C | 2.69% | |
| ACAD | F | 2.64% | |
| RGEN | D | 2.63% | |
| OPK | C | 2.59% | |
| QGEN | D | 2.58% | |
| NVAX | F | 2.48% | |
| VCEL | D | 2.39% | |
| MYGN | F | 2.33% | |
| HALO | B | 2.25% |
PBE Underweight 42 Positions Relative to BOUT
| Symbol | Grade | Weight | |
|---|---|---|---|
| PACS | A | -4.48% | |
| MS | B | -4.47% | |
| LBRDK | A | -4.44% | |
| NEM | D | -4.42% | |
| VIK | A | -4.39% | |
| EXPE | B | -4.28% | |
| EQIX | B | -4.25% | |
| AHR | A | -4.24% | |
| IDCC | A | -4.01% | |
| ETN | B | -3.82% | |
| SPGI | D | -3.81% | |
| EQH | B | -3.78% | |
| CRM | A | -3.73% | |
| BAH | A | -3.73% | |
| DVA | D | -3.71% | |
| PGR | D | -3.63% | |
| CRDO | A | -2.87% | |
| VRNS | D | -2.61% | |
| ULS | B | -2.59% | |
| IR | C | -2.49% | |
| DT | B | -2.49% | |
| NMIH | D | -2.44% | |
| ONON | D | -2.35% | |
| TSM | B | -1.31% | |
| TBBK | D | -1.28% | |
| NOW | A | -1.27% | |
| SCCO | B | -1.22% | |
| SN | C | -1.2% | |
| TCOM | A | -1.14% | |
| BEKE | A | -1.06% | |
| ROAD | B | -0.45% | |
| AXON | B | -0.43% | |
| TPH | D | -0.42% | |
| IBKR | A | -0.42% | |
| CWAN | B | -0.42% | |
| AVGO | B | -0.42% | |
| ALKT | B | -0.42% | |
| GMED | A | -0.41% | |
| CORT | B | -0.41% | |
| ACGL | F | -0.4% | |
| PLMR | D | -0.39% | |
| JD | A | -0.38% |
PBE: Top Represented Industries & Keywords
BOUT: Top Represented Industries & Keywords
Compare ETFs
